Latest Hologic Inc. Stories
BEDFORD, Mass., Feb. 28, 2012 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that the Company has entered into separate, privately-negotiated exchange agreements under which it will retire $500 million in aggregate principal of the Company's outstanding 2.00% Convertible...
BEDFORD, Mass., Jan. 30, 2012 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced its results for the first fiscal quarter ended December 24, 2011. Highlights of the quarter include: Revenues of $472.7 million resulting from year-over-year growth in all four operating...
BEDFORD, Mass., Jan. 25, 2012 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) today announced that company management will participate in the following investor conferences: Glenn Muir, Executive Vice President and Chief Financial Officer, will present at: The Leerink Swann 2012 Global Healthcare Conference in New York City, New York on Wednesday, February 15, 2012 at 11:30 a.m. (Eastern). The 2012 RBC Capital Markets' Global Healthcare Conference in New York City, New York on...
BEDFORD, Mass., Jan. 9, 2012 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that Conceptus, Inc.'s (Conceptus) request for an injunction barring future sales of Hologic's Adiana permanent contraception (Adiana) system has been denied and that no royalty will be due to...
BEDFORD, Mass., Dec. 19, 2011 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced plans to release its first quarter fiscal 2012 operating results on Monday, January 30, 2012 after market close. In conjunction with the release, management will host a conference call on...
BEDFORD, Mass., Dec. 15, 2011 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that the U.S. Food and Drug Administration (FDA) has approved its Cervista HTA (high throughput automation) system for use with the Company's previously approved Cervista human papillomavirus...
BEDFORD, Mass., Dec. 1, 2011 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) today announced that Glenn Muir, Executive Vice President and Chief Financial Officer, will be presenting at the Nasdaq OMX 27th Investor Program in London on Tuesday, December 6, 2011, at 11:15am (GMT). Interested parties are invited to listen to the live audio webcast of the investor presentation on the investor section of Hologic's website at www.hologic.com/investors-overview. An archive of the...
BEDFORD, Mass., Nov. 27, 2011 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the commercial release of its C-View synthesized 2D image reconstruction algorithm that eliminates the need for a conventional 2D mammogram as a component of a tomosynthesis (3D mammography)...
BEDFORD, Mass., Nov. 21, 2011 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will feature some of its newest women's health products at the 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) at McCormick Place in Chicago, November 26...
BEDFORD, Mass., Nov. 7, 2011 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced its results for the fourth fiscal quarter and fiscal year ended September 24, 2011. Highlights of the quarter include: Revenues of $467.0 million resulting from year-over-year growth in all four...
